News

Displaying 161 - 180 of 734

Canada – edible cannabis products may now be sold in Canada

From 16 December 2019, edible cannabis products are permitted to be sold in Canada. These must comply with new regulations for edible, inhalable and topical products, designed to reduce the risk of...

open door

EMCDDA Best practice portal update

Pharmacotherapies for the treatment of cocaine use disorders There are signs that increased cocaine availability in Europe is resulting in growing health costs. Since 2014, the number of new clients entering treatment...

Bursaries for students from ENP countries for the 2020 European Drugs Summer School

Professionals, academics or experts from European Neighbourhood Policy (ENP) countries will have an opportunity to participate in the European Drugs Summer School (EDSS) in 2020, thanks to five bursaries being offered through...

EU4MD networking photo

EU4MD bursaries for the 2020 NIDA International Forum

Professionals, academics and experts from European Neighbourhood Policy (ENP) countries will have the opportunity to participate in the 2020 National Institute on Drug Abuse International Forum, thanks to five bursaries being offered...

New EMCDDA Scientific Committee appointed for the next three years

On 13 December, the EMCDDA Management Board appointed 15 high-level scientists to serve on the agency’s Scientific Committee for the period 2020–22. The selection followed a call for expressions of interest in...

SOLIDIFY project: a broad European partnership stands for a local drug policy based on the principles of harm reduction and supports the implementation of Supervised Drug Consumption Facilities

On 5 and 6 December 2019, 150 participants took part in the final conference of Efus’ SOLIDIFY project, held in Lisbon, Portugal. Co-hosted with the European Monitoring Centre for Drugs and Drug...

close-up of a Euro note

New report highlights wide-ranging impacts of EU drug markets on health and security

Europeans are spending at least EUR 30 billion on drugs each year at retail level, making the drug market a major source of income for organised crime groups in the European Union...

Coming soon: 2019 EU Drug Markets Report from the EMCDDA and Europol

Drug trafficking is a highly profitable commercial activity and remains a core business for organised crime groups across Europe today. Understanding the reality of the European drug market requires a holistic approach...

Alexis Goosdeel, EMCDDA Director

Director's speech: EU-Western Balkans Cooperation on Drugs: Challenges and Perspectives

Occasion: Presentation at the EU-Western Balkans Ministerial Forum on Justice and Home Affairs, 18–19 November 2019, Skopje, North Macedonia 1. Recent trends and developments The drugs situation has become more serious in...

EU fundamental charter 2009-2019

EU Agencies join 10-year anniversary of EU’s Fundamental Rights Charter

The nine EU Justice and Home Affairs Agencies are marking the 10-year anniversary of the EU’s Charter of Fundamental Rights by pledging to continue to respect and promote fundamental rights throughout the...

open door

EMCDDA Best practice portal update

Neurostimulation techniques for the treatment of substance use The continuous research on the treatment of substance use dependence has identified the potential of some neurostimulation techniques to reduce substance use and cravings...

Australian Capital Territory legalises personal cannabis growing and consumption

On 25 September 2019, the Legislative Assembly of the Australian Capital Territory (ACT) approved a law permitting personal cultivation, possession and use of cannabis for recreational purposes. The background note to the...

Visit of the European Parliament LIBE Committee to the EMCDDA

On 30 and 31 October, Member of the European Parliament Caterina Chinnici (Italy, S&D) paid an official visit to the EMCDDA on behalf of the EP’s Committee on Civil Liberties, Justice and...

EU4MD networking photo

News from EU4Monitoring Drugs, the EMCDDA’s technical cooperation project

This content was published in the second EU4MD update released on 22.10.2019. This update also presents a section on partnerships and related activities, upcoming events, and a research corner. Professionalising drug prevention...

EMCDDA at 2019 European Conference on Addictive Behaviours and Dependencies

This week, EMCDDA staff members are revving up for ‘Lisbon Addictions 2019’, the third European Conference on Addictive Behaviours and Dependencies. Taking place from 23–25 October, ‘Lisbon Addictions’ is the largest European...

World experts to review the future of addictions at pioneering European conference

‘The future of addictions: new frontiers for policy, practice and science’ is the theme of the Third European conference on addictive behaviours and dependencies (#LxAddictions19) taking place in Lisbon from 23–25 October...

Registration now open for the ninth European drugs summer school

The University Institute of Lisbon (ISCTE-IUL) and the EU drugs agency (EMCDDA) will be joining forces once again next summer to hold the ninth European drugs summer school (EDSS) on ‘Illicit drugs...

Hepatitis elimination barometer — focus of new report

The EMCDDA is working with its expert network on drug-related infectious diseases (DRID) on an ‘elimination barometer’ for viral hepatitis to help countries assess progress towards eliminating hepatitis C and B among...

Supporting initiatives in the field of drugs policy

This week, the European Commission launched ‘Supporting initiatives in the field of drugs policy’, a new call for proposals for grant applications to support transnational projects in the area of EU drugs...

New EMCDDA manual and training courses for professionalising drug prevention

Advancing the professionalism of the drug prevention workforce in Europe is at the heart of a new European Prevention Curriculum (EUPC) handbook, launched today by the EU drugs agency (EMCDDA). The manual...